This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignees: National Institute of Advanced Industrial Science and Technology, Hokkaido University, Hokusan Co. Ltd. Active years: 2009-2022.
Location History:
- Hokkaido, JP (2009 - 2020)
- Kitahiroshima, JP (2022)
Company Filing History:
4 out of 1,762 
2 out of 442 
2 out of 8 Years Active: 2009-2022
Title: Noriko Itchoda: Innovator in Medical Science
Introduction
Noriko Itchoda is a prominent inventor based in Hokkaido, Japan. She has made significant contributions to the field of medical science, particularly in the development of vaccines and therapeutic agents. With a total of 4 patents to her name, her work has the potential to impact public health positively.
Latest Patents
One of her latest inventions is a malaria transmission-blocking vaccine. This vaccine utilizes an immunogenic protein specifically expressed in the oocyst stage of malaria parasites. It aims to provide an oral transmission-blocking vaccine capable of immunizing various animals involved in the malaria infectious cycle. Another notable patent is related to the therapeutic effect of oral interferon alpha administration on chronic intractable external otitis. This invention offers a composition that can prevent and treat chronic external otitis, demonstrating immediate and sustained effects.
Career Highlights
Noriko Itchoda has worked with esteemed institutions such as the National Institute of Advanced Industrial Science and Technology and Hokkaido University. Her research and innovations have garnered attention in the scientific community, showcasing her dedication to advancing medical science.
Collaborations
She has collaborated with notable coworkers, including Takeshi Matsumura and Noriko Tabayashi. These partnerships have contributed to her successful research endeavors and patent developments.
Conclusion
Noriko Itchoda's innovative work in medical science, particularly in vaccine development and therapeutic agents, highlights her significant contributions to public health. Her patents reflect her commitment to addressing critical health challenges, making her a noteworthy inventor in her field.